Enzo Biochem (ENZ)
0.6531 -0.0049 (-0.74%) 01/24/25 [NYSE]
0.6203 x 1,300 1.3000 x 100
Realtime by (Cboe BZX)
0.6203 x 1,300 1.3000 x 100
Realtime 0.6444 -0.0087 (-) 01/24/25
for Fri, Jan 24th, 2025
Fiscal Year End Date: 07/31
07-2019 | 07-2018 | 07-2017 | 07-2016 | 07-2015 | |
Sales | 81,170 | 101,013 | 105,086 | 102,773 | 97,599 |
Cost of Goods | 57,922 | 60,385 | 59,478 | 57,190 | 54,772 |
Gross Profit | 23,248 | 40,628 | 45,608 | 45,583 | 42,827 |
Operating Expenses | 22,437 | 53,177 | 49,234 | -1,075 | 44,805 |
Operating Income | 1,733 | -12,164 | -3,148 | 46,848 | -1,206 |
Other Income | 756 | 746 | 644 | -488 | -1,086 |
Pre-tax Income | 2,489 | -11,418 | -2,504 | 46,360 | -2,292 |
Income Tax | N/A | -1,097 | N/A | 1,074 | -7 |
Net Income Continuous | 2,489 | -10,321 | -2,504 | 45,286 | -2,285 |
Net Income | $2,489 | $-10,321 | $-2,504 | $45,286 | $-2,285 |
EPS Basic Total Ops | 0.05 | -0.22 | -0.05 | 0.98 | -0.05 |
EPS Basic Continuous Ops | 0.05 | -0.22 | -0.05 | 0.98 | -0.05 |
EPS Diluted Total Ops | 0.05 | -0.22 | -0.05 | 0.97 | -0.05 |
EPS Diluted Continuous Ops | 0.05 | -0.22 | -0.05 | 0.97 | -0.05 |
EPS Diluted Before Non-Recurring Items | -0.56 | N/A | N/A | N/A | N/A |
EBITDA(a) | $4,769 | $-9,034 | $450 | $50,688 | $2,583 |